| 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: the Task Force for dual antiplatelet therapy in coronary … M Valgimigli, H Bueno, RA Byrne, JP Collet, F Costa, A Jeppsson, P Jüni, ... European heart journal 39 (3), 213-260, 2018 | 3574* | 2018 |
| Long-term use of ticagrelor in patients with prior myocardial infarction MP Bonaca, DL Bhatt, M Cohen, PG Steg, RF Storey, EC Jensen, ... New England Journal of Medicine 372 (19), 1791-1800, 2015 | 2139 | 2015 |
| Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial M Valgimigli, A Gagnor, P Calabró, E Frigoli, S Leonardi, T Zaro, ... The Lancet 385 (9986), 2465-2476, 2015 | 1382 | 2015 |
| Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a … F Costa, D Van Klaveren, S James, D Heg, L Räber, F Feres, T Pilgrim, ... The Lancet 389 (10073), 1025-1034, 2017 | 1031 | 2017 |
| Long-term dual antiplatelet therapy for secondary prevention of cardiovascular events in the subgroup of patients with previous myocardial infarction: a collaborative meta … JA Udell, MP Bonaca, JP Collet, AM Lincoff, DJ Kereiakes, F Costa, ... European heart journal 37 (4), 390-399, 2016 | 448 | 2016 |
| Bivalirudin or unfractionated heparin in acute coronary syndromes M Valgimigli, E Frigoli, S Leonardi, M Rothenbühler, A Gagnor, P Calabrò, ... New England Journal of Medicine 373 (11), 997-1009, 2015 | 401 | 2015 |
| Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: meta-analysis of randomised controlled trials EP Navarese, F Andreotti, V Schulze, M Kołodziejczak, A Buffon, ... bmj 350, 2015 | 373 | 2015 |
| Trade-off of myocardial infarction vs. bleeding types on mortality after acute coronary syndrome: lessons from the Thrombin Receptor Antagonist for Clinical Event Reduction in … M Valgimigli, F Costa, Y Lokhnygina, RM Clare, L Wallentin, DJ Moliterno, ... European heart journal 38 (11), 804-810, 2017 | 298 | 2017 |
| Dual antiplatelet therapy duration based on ischemic and bleeding risks after coronary stenting F Costa, D Van Klaveren, F Feres, S James, L Räber, T Pilgrim, MK Hong, ... Journal of the American College of Cardiology 73 (7), 741-754, 2019 | 252 | 2019 |
| Is Bare-Metal Stent Implantation Still Justifiable in High Bleeding Risk Patients Undergoing Percutaneous Coronary Intervention? JACC Cardiovascular Intervention 9 (5), 426-436, 2016 | 166 | 2016 |
| Acute kidney injury after radial or femoral access for invasive acute coronary syndrome management: AKI-MATRIX G Andò, B Cortese, F Russo, M Rothenbühler, E Frigoli, G Gargiulo, ... Journal of the American College of Cardiology 69 (21), 2592-2603, 2017 | 153 | 2017 |
| ESC Scientific Document Group; ESC Committee for Practice Guidelines (CPG); ESC National Cardiac Societies. 2017 ESC focused update on dual antiplatelet therapy in coronary … M Valgimigli, H Bueno, RA Byrne, JP Collet, F Costa, A Jeppsson, P Jüni, ... Eur Heart J 39 (3), 213, 2018 | 124 | 2018 |
| Impact of clinical presentation on ischaemic and bleeding outcomes in patients receiving 6-or 24-month duration of dual-antiplatelet therapy after stent implantation: a pre … F Costa, P Vranckx, S Leonardi, E Moscarella, G Ando, P Calabro, ... European Heart Journal 36 (20), 1242-1251, 2015 | 105 | 2015 |
| Impact of clinical presentation on ischaemic and bleeding outcomes in patients receiving 6-or 24-month duration of dual-antiplatelet therapy after stent implantation: a pre … F Costa, P Vranckx, S Leonardi, E Moscarella, G Ando, P Calabro, ... European Heart Journal 36 (20), 1242-1251, 2015 | 105 | 2015 |
| Incremental value of the CRUSADE, ACUITY, and HAS‐BLED risk scores for the prediction of hemorrhagic events after coronary stent implantation in patients undergoing long or … F Costa, JG Tijssen, S Ariotti, S Giatti, E Moscarella, P Guastaroba, ... Journal of the American Heart Association 4 (12), e002524, 2015 | 98 | 2015 |
| Standardized classification and framework for reporting, interpreting, and analysing medication non-adherence in cardiovascular clinical trials: a consensus report from the Non … M Valgimigli, HM Garcia-Garcia, B Vrijens, P Vranckx, EP McFadden, ... European heart journal 40 (25), 2070-2085, 2019 | 77 | 2019 |
| Impact of proton pump inhibitors on clinical outcomes in patients treated with a 6-or 24-month dual-antiplatelet therapy duration: Insights from the PROlonging Dual … G Gargiulo, F Costa, S Ariotti, S Biscaglia, G Campo, G Esposito, ... American heart journal 174, 95-102, 2016 | 71 | 2016 |
| The Rotterdam radial access research: ultrasound-based radial artery evaluation for diagnostic and therapeutic coronary procedures F Costa, MAH van Leeuwen, J Daemen, R Diletti, F Kauer, RJ van Geuns, ... Circulation: Cardiovascular Interventions 9 (2), e003129, 2016 | 70 | 2016 |
| Dual antiplatelet therapy duration after coronary stenting in clinical practice: results of an EAPCI survey M Valgimigli, F Costa, R Byrne, M Haude, A Baumbach, S Windecker, ... EuroIntervention: journal of EuroPCR in collaboration with the Working Group …, 2015 | 62 | 2015 |
| Impact of vascular access on acute kidney injury after percutaneous coronary intervention G Andò, F Costa, O Trio, G Oreto, M Valgimigli Cardiovascular Revascularization Medicine 17 (5), 333-338, 2016 | 44 | 2016 |
Ph.Gabriel STEGUniversité de Paris, Paris, Franceبريد إلكتروني تم التحقق منه على aphp.fr
